Acute bronchial asthma in emergency care in a city of Pernambuco during the COVID-19 pandemic: Case report




Asthma; Symptom flare up; Therapeutics; Ambulatory care; Coronavirus infections.


Bronchial asthma is a chronic disease of the airways, heterogeneous and of unknown etiology. In Brazil, decompensated bronchial asthma is the fourth leading cause of hospitalizations, with a higher incidence in the Northeast and Southeast regions, with descending mortality rates. The most common symptoms and signs are dyspnea, wheezing, retrosternal chest tightness and cough, resulting from the inflammatory process, with bronchial hyperreactivity and bronchoconstriction. This article aims to alert health professionals about the early diagnosis and treatment of exacerbated asthma in an emergency in the pandemic context of COVID-19, through this case report. Also dealing with the differential diagnosis in respiratory symptoms for COVID-19 with assessment of epidemiological risks and radiography, not very sensitive and specific for COVID-19, but widely available. This case report is about a 19-year-old Caucasian woman, single, born in Caruaru-PE, with complaints of low intensity chest discomfort, dyspnea and fatigue for three days, presenting exacerbation of symptoms in the last four hours, with previous diagnosis of asthma since childhood, currently with treatment interrupted due to fear of worsening for COVID-19 and waking up at night every day during the last month. After therapeutic conduct and clinical improvement, the patient was discharged with instructions on continuity of oral corticosteroids, return to bronchial asthma control therapy, need for follow-up in Primary Health Care (PHC) and symptoms of severity for bronchial asthma and COVID- 19 that indicate the need for emergency care.


Boulet, L. P. et al. (2019). The global initiative for asthma (GINA): 25 years later. European Respiratory Journal, 54(2).

Brasil. Ministério da Saúde. (2021). Sistema de Informações Hospitalares do SUS (SIH/SUS). dex.php?area=060502.

Brasil. Ministério da Saúde. (2020). Orientações para manejo de pacientes com COVID-19. une/18/Covid19-Orientac--o--esManejoPacientes.pdf.

Cardoso, T. D. A., Roncada, C., Silva, E. R. D., Pinto, L. A., Jones, M. H., Stein, R. T., & Pitrez, P. M. (2017). The impact of asthma in Brazil: a longitudinal analysis of data from a Brazilian national database system. Jornal brasileiro de pneumologia, 43(3), 163-168.

Chesné, J. et al. (2014). IL-17 in severe asthma. Where do we stand? Am. J. Respir. Crit. Care Med. 190, 1094–1101.

Custovic, A. (2015) To what extent is allergen exposure a risk factor for the development of allergic disease? Clin. Exp. Allergy 45, 54–62

Gupta, S., Price, C., Agarwal, G., Chan, D., Goel, S., Boulet, L. P., & Straus, S. E. (2019). The Electronic Asthma Management System (eAMS) improves primary care asthma management. European Respiratory Journal, 53(4).

Harkness, L. M., Ashton, A. W. & Burgess, J. K. (2015). Asthma is not only an airway disease, but also a vascular disease. Pharmacol. Ther. 148, 17–33 (2015).

Hartmann-Boyce, J., Gunnell, J., Drake, J., Otunla, A., Suklan, J., Schofield, E., & Dennison, P. (2020). Asthma and COVID-19: review of evidence on risks and management considerations. BMJ Evidence-Based Medicine.

Holgate, S., Wenzel, S., Postma, D. et al. (2015). Asthma. Nat Rev Dis Primers 1, 15025.

Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., & Zhao, J. (2020). Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology, 146(1), 110-118.

Liu, S., Zhi, Y., & Ying, S. (2020). COVID-19 and asthma: reflection during the pandemic. Clinical reviews in allergy & immunology, 59, 78-88.

Longo, D. L., Kasper, D. L., Jameson, J. L., Fauci, A. S., Hauser, S. L., & Loscalzo, J. (2020). Medicina interna de Harrison. In Medicina interna de Harrison. 20. ed. Porto Alegre. Artmed.

Lundbäck, B., Backman, H., Lötvall, J., & Rönmark, E. (2016). Is asthma prevalence still increasing?. Expert review of respiratory medicine, 10(1), 39-51.

Martinez-Gonzalez, I., Steer, C. A. & Takei, F. (2015). Lung ILC2s link innate and adaptive responses in allergic inflammation. Trends Immunol. 36, 189–195 (2015).

Mendes, N. F., Jara, C. P., Mansour, E., Araújo, E. P., & Velloso, L. A. (2021). Asthma and COVID-19: a systematic review. Allergy, Asthma & Clinical Immunology, 17(1), 1-12.

Pizzichini, M. M. M., Carvalho-Pinto, R. M. D., Cançado, J. E. D., Rubin, A. S., Cerci Neto, A., Cardoso, A. P., & Cukier, A. (2020). Recomendações para o manejo da asma da Sociedade Brasileira de Pneumologia e Tisiologia-2020. Jornal Brasileiro de Pneumologia, 46(1).

Papi, A. et al. (2018). Asthma, Asthma–Science Direct, 391(24), 783-800.

WHO. World Health Organization. (2020). Clinical management of severe acute respiratory infection when novel coronavirus (‎‎‎ nCoV)‎‎‎ infection is suspected: interim guidance, 25 January 2020 (No. WHO/nCoV/Clinical/2020.2). World Health Organization.

Wu, T. D., Brigham, E. P., & McCormack, M. C. (2019). Asthma in the primary care setting. Medical Clinics, 103(3), 435-452.

Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., & Cao, B. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The lancet, 395(10229), 1054-1062.



How to Cite

AFONSO, T. de O.; SANTOS, S. L. dos; ARAÚJO, G. B.; CARVALHO, I. de O.; BORGES, G. D.; BARROS, C. V. M. de L.; CARVALHO, S. B. de; DIAS, E. M. da L.; MACHADO, M. G. de O.; BARBOSA, R. R. R.; VIEIRA, A. I. A.; COSTA, L. C.; LOURES, L. L. da S.; BARBOSA, B. da L.; PORTO, G. M. de A.; DELAIA, I. N.; SOUZA, E. P. D. de; SILVA, M. T. da; SOUSA, C. L. T. C. de; SANTOS, A. de C. I. dos; DIAS, F. A. O. Acute bronchial asthma in emergency care in a city of Pernambuco during the COVID-19 pandemic: Case report. Research, Society and Development, [S. l.], v. 10, n. 5, p. e52910514959, 2021. DOI: 10.33448/rsd-v10i5.14959. Disponível em: Acesso em: 29 jan. 2023.



Health Sciences